Page last updated: 2024-12-06

imidazolidinyl urea

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Imidazolidinyl urea, also known as diazolidinyl urea, is a synthetic compound widely used in cosmetics and personal care products as a humectant and preservative. It is synthesized by reacting urea with formaldehyde. Imidazolidinyl urea has been shown to have antimicrobial properties, inhibiting the growth of bacteria and fungi. This property makes it a valuable ingredient in preventing spoilage and extending the shelf life of products. However, concerns have been raised about its potential for skin irritation and allergic reactions. Research studies have investigated its safety profile and potential health effects, particularly its allergenic potential and possible interactions with other ingredients. The study of imidazolidinyl urea is crucial for understanding its benefits and risks in personal care products, leading to the development of safer and more effective formulations.'

imidazolidinyl urea: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID38258
CHEMBL ID65433
CHEBI ID51805
SCHEMBL ID34461
MeSH IDM0048068

Synonyms (90)

Synonym
smr001233448
MLS002154142 ,
c11h16n8o8
PRESTWICK3_001071
BSPBIO_001082
cas-39236-46-9
BPBIO1_001192
NCGC00179313-01
n,n-methylenebis[n-[3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]urea]
39236-46-9
1-[3-(hydroxymethyl)-2,5-dioxo-imidazolidin-4-yl]-3-[[[3-(hydroxymethyl)-2,5-dioxo-imidazolidin-4-yl]carbamoylamino]methyl]urea
imidurea
imidurea (nf)
D04513
PRESTWICK2_001071
AB00514030
NCGC00164388-01
imidazolinidyl urea
n,n''-methylenebis(n'-(3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)urea)
n,n''-methylenebis(n'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidin- yl)urea
methanebis(n,n'-(5-ureido-2,4-diketotetrahydroimidazole)-n,n-dimethylol)
n,n'-methylenebis(n'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea)
einecs 254-372-6
1,1'-methylenebis(3-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea)
urea, n,n''-methylenebis(n'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidin- yl)-
urea, n,n''-methylenebis(n'-(1-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-
germall 115
urea, n,n''-methylenebis(n'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)-
n,n''-methylenebis(n'-(1-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea)
PRESTWICK0_001071
PRESTWICK1_001071
SPBIO_002991
n',n'''-methanediylbis{1-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]urea}
imidazolidinyl urea
n,n''-methylenebis(n'-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea)
CHEBI:51805 ,
CHEMBL65433
1-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoylamino]methyl]urea
FT-0658132
HMS1571G04
HMS2098G04
tox21_302325
dtxcid0020151
dtxsid2040151 ,
NCGC00255574-01
tox21_112112
I0665
n,n'-methylenebis[n'-(3-hydroxymethyl-2,5-dioxo-4-imidazolidinyl)urea]
HMS2230O16
1,1'-methylenebis(3-(3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl)urea)
imidurea [nf]
ec 254-372-6
unii-m629807atl
m629807atl ,
S10971
AKOS015895558
S5212
HMS3369E04
1,1'-methylenebis(3-(3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl)urea
imidurea [vandf]
imidurea [mart.]
imidurea [mi]
imidurea [usp-rs]
imidazolidinyl urea [inci]
imidurea [ii]
imidazolidinyl urea [vandf]
CCG-221071
SCHEMBL34461
CS-4609
NCGC00179313-03
1-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-3-[[[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]c
1-[3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-3-[[[[[3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]amino]-oxomethyl]amino]methyl]urea
cid_38258
1-(2,5-diketo-3-methylol-imidazolidin-4-yl)-3-[[(2,5-diketo-3-methylol-imidazolidin-4-yl)carbamoylamino]methyl]urea
bdbm66981
1-[3-(hydroxymethyl)-2,5-bis(oxidanylidene)imidazolidin-4-yl]-3-[[[3-(hydroxymethyl)-2,5-bis(oxidanylidene)imidazolidin-4-yl]carbamoylamino]methyl]urea
HY-B1158
mfcd00221482
sr-01000841816
SR-01000841816-2
3-[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]-1-[({[3-(hydroxymethyl)-2,5-dioxoimidazolidin-4-yl]carbamoyl}amino)methyl]urea
imidurea, united states pharmacopeia (usp) reference standard
imidurea, pharmaceutical secondary standard; certified reference material
HMS3715G04
DB14075
AS-15260
NCGC00179313-05
Q2737856
n,n'-methylenebis[n'-[3-(hydroxymethyl)-2,5-dioxo-4-imidazolidinyl]-urea
EN300-19627076

Research Excerpts

Treatment

ExcerptReferenceRelevance
"Treatment with imidazolidinyl urea induced a loss of cell viability and accelerated inflammation in a concentration-dependent manner."( Cell chip-based monitoring of toxic effects of cosmetic compounds on skin fibroblast cells.
An, JH; Choi, JW; Chun, JR; Kafi, MD; Lee, JS; Oh, BK, 2012
)
0.72

Toxicity

ExcerptReferenceRelevance
" The time at which a compound showed the greatest toxicity to the cell cycle was definable for APG (between 20 and 50 min postfertilization) and IU (from fertilization to 50 min later); the other compounds being toxic throughout division."( Mechanisms of cytotoxicity by cosmetic ingredients in sea urchin eggs.
Amouroux, I; Girard, JP; Noël, H; Pesando, D, 1999
)
0.3

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

ExcerptRelevanceReference
" A positive dose-response relationship was found."( Standardization of the TRUE Test imidazolidinyl urea and diazolidinyl urea patches.
Agner, T; Andersen, KE; Björkner, B; Bruze, M; Frosch, PJ; Gruvberger, B; Hoeck, U; Kreilgaard, B; Menné, T; Sommer, J, 2001
)
0.59
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (14 Product(s))

Product Categories

Product CategoryProducts
Beauty & Personal Care13
Baby & Kids Products1

Products

ProductBrandCategoryCompounds Matched from IngredientsDate Retrieved
Blue-Emu Original Blue Emu Super Strength -- 12 ozBlue-EmuBeauty & Personal Careallantoin, cetyl alcohol, cholecalciferol, panthenol, dimethyl sulfone, D glucosamine, glycerin, dimethicone, imidazolidinyl urea, methylparaben, oleyl alcohol, propylparaben, retinyl palmitate, stearic acid, triethanolamine2024-11-29 10:47:42
Blue-Emu Original Blue Emu Super Strength -- 4 ozBlue-EmuBeauty & Personal Careallantoin, cetyl alcohol, cholecalciferol, panthenol, dimethyl sulfone, D glucosamine, glycerin, dimethicone, imidazolidinyl urea, methylparaben, oleyl alcohol, propylparaben, retinyl palmitate, stearic acid, triethanolamine2024-11-29 10:47:42
Fairy Tales Lice Prevention Rosemary Repel Conditioning Spray -- 32 fl ozFairy TalesBaby & Kids Products1,3 propanediol, citronella, panthenol, dicetyldimonium chloride, imidazolidinyl urea2024-11-29 10:47:42
Herbatint Chamomile Shampoo -- 8.79 fl ozHerbatintBeauty & Personal Carechamomile, cocamidopropyl betaine, saffron, imidazolidinyl urea, sodium benzoate2024-11-29 10:47:42
Herbatint Normalizing Shampoo Aloe Vera -- 8.79 fl ozHerbatintBeauty & Personal Carecocamidopropyl betaine, imidazolidinyl urea, propylene glycol, sodium benzoate2024-11-29 10:47:42
Herbatint Permanent Hair Color Gel 10C Swedish Blonde -- 135 mLHerbatintBeauty & Personal Careisopropyl alcohol, citric acid, cetyl alcohol, citric acid, ethanolamine, etidronic acid, imidazolidinyl urea, oleic acid, propylene glycol, simethicone, sodium benzoate, sodium metabisulfite2024-11-29 10:47:42
Herbatint Permanent Hair Color Gel 2N Brown -- 135 mLHerbatintBeauty & Personal Carecitric acid, p-phenylenediamine, cetyl alcohol, citric acid, ethanolamine, etidronic acid, imidazolidinyl urea, oleic acid, propylene glycol, simethicone, sodium benzoate, sodium metabisulfite2024-11-29 10:47:42
Herbatint Permanent Hair Color Gel 3N Dark Chestnut -- 135 mLHerbatintBeauty & Personal Careisopropyl alcohol, P-phenylenediamine, cetyl alcohol, ethanolamine, etidronic acid, imidazolidinyl urea, propylene glycol, simethicone, sodium benzoate2024-11-29 10:47:42
Herbatint Permanent Hair Color Gel 4M Mahogany Chestnut -- 135 mLHerbatintBeauty & Personal Care2-amino-3-hydroxypyridine, m-aminophenol, p-aminophenol, p-phenylenediamine, cetyl alcohol, ethanolamine, etidronic acid, imidazolidinyl urea, methyl benzoate, propylene glycol, simethicone2024-11-29 10:47:42
Herbatint Permanent Hair Color Gel 4N Chestnut -- 135 mLHerbatintBeauty & Personal Carep-phenylenediamine, cetyl alcohol, ethanolamine, etidronic acid, imidazolidinyl urea, oleic acid, propylene glycol, simethicone, sodium benzoate2024-11-29 10:47:42
Herbatint Permanent Hair Color Gel 6N Dark Blonde -- 135 mLHerbatintBeauty & Personal Carecitric acid, cetyl alcohol, citric acid, ethanolamine, etidronic acid, imidazolidinyl urea, oleic acid, propylene glycol, simethicone, sodium benzoate, sodium metabisulfite2024-11-29 10:47:42
Herbatint Permanent Hair Color Gel 7N Blonde -- 135 mLHerbatintBeauty & Personal Careisopropyl alcohol, citric acid, p-phenylenediamine, cetyl alcohol, citric acid, ethanolamine, etidronic acid, imidazolidinyl urea, oleic acid, propylene glycol, simethicone, sodium metabisulfite2024-11-29 10:47:42
Herbatint Permanent Hair Color Gel 8N Light Blonde -- 135 mLHerbatintBeauty & Personal Careisopropyl alcohol, citric acid, cetyl alcohol, citric acid, ethanolamine, etidronic acid, imidazolidinyl urea, oleic acid, propylene glycol, simethicone, sodium benzoate2024-11-29 10:47:42
NutriBiotic Skin Serum -- 1 fl ozNutriBioticBeauty & Personal Careascorbyl palmitate, CoQ10, tocopherol, DMAE, tocopherol, glycerin, imidazolidinyl urea, linalool, linoleic acid, mannitol, methylparaben, phenoxyethanol, propylparaben, retinyl palmitate, betasitosterol, sodium metabisulfite, alpha lipoic acid, tocotrienol, ubiquinone2024-11-29 10:47:42

Roles (1)

RoleDescription
antimicrobial agentA substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
ureas
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
AR proteinHomo sapiens (human)Potency30.63790.000221.22318,912.5098AID1259243
chromobox protein homolog 1Homo sapiens (human)Potency100.00000.006026.168889.1251AID540317
importin subunit beta-1 isoform 1Homo sapiens (human)Potency0.00735.804836.130665.1308AID540253
snurportin-1Homo sapiens (human)Potency0.00735.804836.130665.1308AID540253
GTP-binding nuclear protein Ran isoform 1Homo sapiens (human)Potency0.00735.804816.996225.9290AID540253
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, BCL-2-RELATED PROTEIN A1Homo sapiens (human)EC50 (µMol)350.00008.0570121.1218338.0000AID2765
bcl-2-like protein 11 isoform 1Homo sapiens (human)EC50 (µMol)350.00008.0570121.1218338.0000AID2765
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (23)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID1745845Primary qHTS for Inhibitors of ATXN expression
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID91435Inhibition against HIV-1 integrase at 1 mM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID91436Inhibition against HIV-1 integrase at 200 uM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID91437Inhibition against HIV-1 integrase at 25 uM2000Journal of medicinal chemistry, Jun-01, Volume: 43, Issue:11
Developing a dynamic pharmacophore model for HIV-1 integrase.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (67)

TimeframeStudies, This Drug (%)All Drugs %
pre-199013 (19.40)18.7374
1990's9 (13.43)18.2507
2000's14 (20.90)29.6817
2010's23 (34.33)24.3611
2020's8 (11.94)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 62.73

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index62.73 (24.57)
Research Supply Index4.32 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index103.53 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (62.73)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (4.23%)5.53%
Reviews5 (7.04%)6.00%
Case Studies12 (16.90%)4.05%
Observational1 (1.41%)0.25%
Other50 (70.42%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]